Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2017 R21 RFA-CA-16-001 MALMSTADT, NOAH UNIVERSITY OF SOUTHERN CALIFORNIA A Target-Directed Reagent Pipeline via Microfluidic mRNA Display Complete
2000 R43 PAR-99-101 KOGON, ALEX A BIOLINX, LLC THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING Complete
2002 R43 PAR-01-105 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER Complete
2006 R21 RFA-CA-06-004 HSI, ERIC CLEVELAND CLINIC LERNER COL/MED-CWRU CHARACTERIZATION OF METHODS FOR PRESERVATION OF PHOSPHOPROTEINS IN FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 MC GOWN, LINDA B. RENSSELAER POLYTECHNIC INSTITUTE HYBRIDIZATION OF PROMOTER DNA TARGETS IN CHROMATIN TO DISCOVER REGULATORY PROTEIN Complete
2013 R21 RFA-CA-12-002 CASTRO, CARLOS E. OHIO STATE UNIVERSITY NANOSCALE TOOLS FOR FUNCTIONAL STUDIES OF CANCER-RELEVANT CHROMATIN MODIFICATIONS Complete
2016 R21 RFA-CA-15-002 SADEGHI , SAMAN UNIVERSITY OF CALIFORNIA LOS ANGELES ELECTROCHEMICAL SYNTHESIS OF RADIOPHARMACEUTICALS Complete
2019 R33 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Complete
2000 R21 PAR-99-102 GRIFFITH, JEFFREY K UNIVERSITY OF NEW MEXICO PROGNOSTIC VALUE OF TELOMERE DNA IN PROSTATE BIOPSY Complete
2002 R33 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2005 R33 RFA-CA-05-003 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO TYPING THE TRANSCRIPTOME IN CANCER USING SPLICING ARRAY Complete
2008 R21 RFA-CA-07-037 KNUDSEN, BEATRICE S FRED HUTCHINSON CANCER RESEARCH CENTER TISSUE LYSATES FOR STUDIES OF PROTEIN PHOSPHORYLATION Complete
2011 R21 RFA-CA-10-005 SHENDURE, JAY ASHOK UNIVERSITY OF WASHINGTON ULTRASENSITIVE IDENTIFICATION AND PRECISE QUANTITATION OF LOW FREQUENCY SOMATIC M Complete
2015 R33 RFA-CA-14-004 CARON, MARC G. DUKE UNIVERSITY A CANCER RAINBOW MOUSE FOR SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES Complete
2018 R33 RFA-CA-17-013 INCE, TAN A. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers Complete
1999 R43 PAR-98-066 RICHTERICH, PETER CODONCODE CORPORATION SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION Complete
2002 R21 PAR-01-104 YEUNG, EDWARD S. IOWA STATE UNIVERSITY SINGLE-MOLECULE IMMUNOASSAY AND DNA SCREENING Complete
2004 R44 PAR-01-105 BATTRELL, CHARLES FRED MICRONICS, INC. MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER Complete
2007 R43 RFA-CA-07-010 KRAVITZ, RACHEL HANNAH NEOCLONE BIOTECHNOLOGY INTERNATIONAL A NOVEL PLATFORM FOR MINING THE REPERTOIRE OF ANTIGEN-SPECIFIC B CELLS Complete
2010 R33 RFA-CA-09-007 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT DISCOVERY PLATFORM FOR CANCER ANTIGENS Complete
2014 R43 PAR-13-327 FELLMANN, CHRISTOF MIRIMUS, INC. RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO Complete
2017 R33 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES Complete
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2007 R21 RFA-CA-07-002 SEGALL, JEFFREY E ALBERT EINSTEIN COLLEGE OF MEDICINE DEVELOPMENT OF AN IN VIVO METASTASIS SCREEN Complete
2009 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2013 R33 RFA-CA-13-002 HSIAO, SHIH-CHIA ADHEREN, INC. THE DEVELOPMENT OF A MICROSCOPY-BASED CELL-ARRAY TOXICITY ASSAY FOR QUANTIFYING C Complete
2017 R21 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing Complete
2000 R43 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2006 R21 RFA-CA-06-004 COTE, RICHARD JAMES UNIVERSITY OF SOUTHERN CALIFORNIA INTEGRATED MICRODEVICE TO CAPTURE AND DETECT CIRCULATING TUMOR CELLS Complete
2009 R21 RFA-CA-08-006 CHAREST, JOSEPH LEO CHARLES STARK DRAPER LABORATORY MICROFLUIDIC 3D SCAFFOLD ASSAY FOR CANCER CELL MIGRATION AND INTRAVASATION Complete
2013 R21 RFA-CA-12-002 BAI, MINGFENG UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NOVEL THERANOSTIC PLATFORM FOR TARGETED CANCER THERAPY AND TREATMENT MONITORING Complete
2016 R21 RFA-CA-15-002 SEGAL, DAVID J UNIVERSITY OF CALIFORNIA AT DAVIS CRISPR-BASED EPIGENETIC MODIFIERS Complete
2019 R33 RFA-CA-18-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models Complete
2000 R21 PAR-99-102 OH, SEAJIN SRI INTERNATIONAL AFM BASED TECHNIQUE--ANALYZES EXPRESSION IN CANCER CELLS Complete
2002 R33 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2005 R33 RFA-CA-05-003 SHIBATA, DARRYL K UNIVERSITY OF SOUTHERN CALIFORNIA HOW DO COLORECTAL CANCERS ARISE DESPITE SURVEILLANCE? Complete
2008 R33 RFA-CA-07-034 POOLE, LESLIE B. WAKE FOREST UNIVERSITY HEALTH SCIENCES PROTEOMIC PROFILING OF CANCER-RELATED REDOX SIGNALING PATHWAYS Complete
2011 R21 RFA-CA-10-005 HUANG, SONGPING D KENT STATE UNIVERSITY AT KENT PRUSSIAN BLUE NANOPARTICLES AS CELLULAR T1 MRI CONTRAST AGENTS Complete
2015 R33 RFA-CA-14-004 ZHU, HENG JOHNS HOPKINS UNIVERSITY DEVELOPMENT OF A VIRION DISPLAY (VIRD) ARRAY TO PROFILE HUMAN GPCR INTERACTIONS Complete
1999 R43 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 WYMAN, ROBERT J YALE UNIVERSITY GENETIC METHODS FOR DETECTING GAP JUNCTION COMMUNICATION Complete
2007 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2010 R42 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2014 R44 PAR-13-327 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2017 R33 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity Complete
1999 R21 PAR-98-067 BENSIMON, AARON PASTEUR INSTITUTE DETECTION OF GENOMIC ALTERATIONS BY MOLECULAR COMBING Complete

Pages